ALNYLAM PHARMACEUTICALS, INC. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ALNYLAM PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ALNYLAM PHARMACEUTICALS, INC.. ALNYLAM PHARMACEUTICALS, INC. is a 10% Owner in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and a 10% Owner in Regulus Therapeutics Inc. ($RGLS).
Address: 300 THIRD STREET, 3RD FLOOR CAMBRIDGE 02142 MA
Companies in which ALNYLAM PHARMACEUTICALS, INC. is an Insider
ALNYLAM PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ALNYLAM PHARMACEUTICALS, INC.: 10% Owner
Holdings: 4,896,716 shares
Current Value: $198,121,129
Latest Transaction: Feb 24 2016
$ALNY Market Capitalization: $3.49B
$ALNY Previous Close: $40.46
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Regulus Therapeutics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ALNYLAM PHARMACEUTICALS, INC.: 10% Owner
Holdings: 4,896,716 shares
Current Value: $6,855,402
Latest Transaction: Feb 24 2016
$RGLS Market Capitalization: $72.77M
$RGLS Previous Close: $1.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of ALNYLAM PHARMACEUTICALS, INC.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24 2016 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 7.18 | 1,000,000 | 7,180,000 | 4,896,716 | 5.9 M to 4.9 M (-16.96 %) |
| Feb 24 2016 | ALNY | ALNYLAM PHARMACEUT ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 7.18 | 1,000,000 | 7,180,000 | 4,896,716 | 5.9 M to 4.9 M (-16.96 %) |
| Oct 24 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 15.19 | 1,850 | 28,109 | 5,896,716 | 5.9 M to 5.9 M (-0.03 %) |
| Oct 24 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 14.24 | 1,700 | 24,202 | 5,898,566 | 5.9 M to 5.9 M (-0.03 %) |
| Oct 24 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 14.00 | 109,534 | 1,533,125 | 5,900,266 | 6 M to 5.9 M (-1.82 %) |
| Oct 17 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.79 | 3,000 | 20,371 | 6,009,800 | 6 M to 6 M (-0.05 %) |
| Oct 17 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.76 | 4,800 | 32,450 | 6,012,800 | 6 M to 6 M (-0.08 %) |
View all ALNYLAM PHARMACEUTICALS, INC. insider transactions.